280 related articles for article (PubMed ID: 29378233)
1. In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain.
Modarres HP; Janmaleki M; Novin M; Saliba J; El-Hajj F; RezayatiCharan M; Seyfoori A; Sadabadi H; Vandal M; Nguyen MD; Hasan A; Sanati-Nezhad A
J Control Release; 2018 Mar; 273():108-130. PubMed ID: 29378233
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic organ-on-chip technology for blood-brain barrier research.
van der Helm MW; van der Meer AD; Eijkel JC; van den Berg A; Segerink LI
Tissue Barriers; 2016; 4(1):e1142493. PubMed ID: 27141422
[TBL] [Abstract][Full Text] [Related]
3. Biomimetic drug-delivery systems for the management of brain diseases.
Chen YX; Wei CX; Lyu YQ; Chen HZ; Jiang G; Gao XL
Biomater Sci; 2020 Feb; 8(4):1073-1088. PubMed ID: 31728485
[TBL] [Abstract][Full Text] [Related]
4. Organ-on-a-Chip Systems: Microengineering to Biomimic Living Systems.
Zheng F; Fu F; Cheng Y; Wang C; Zhao Y; Gu Z
Small; 2016 May; 12(17):2253-82. PubMed ID: 26901595
[TBL] [Abstract][Full Text] [Related]
5. New experimental models of the blood-brain barrier for CNS drug discovery.
Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L
Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770
[TBL] [Abstract][Full Text] [Related]
6. Blood brain barrier: A tissue engineered microfluidic chip.
Musafargani S; Mishra S; Gulyás M; Mahalakshmi P; Archunan G; Padmanabhan P; Gulyás B
J Neurosci Methods; 2020 Feb; 331():108525. PubMed ID: 31756396
[TBL] [Abstract][Full Text] [Related]
7. A tissue chip with integrated digital immunosensors: In situ brain endothelial barrier cytokine secretion monitoring.
Su SH; Song Y; Stephens A; Situ M; McCloskey MC; McGrath JL; Andjelkovic AV; Singer BH; Kurabayashi K
Biosens Bioelectron; 2023 Mar; 224():115030. PubMed ID: 36603283
[TBL] [Abstract][Full Text] [Related]
8. Microphysiological systems for recapitulating physiology and function of blood-brain barrier.
Seo S; Kim H; Sung JH; Choi N; Lee K; Kim HN
Biomaterials; 2020 Feb; 232():119732. PubMed ID: 31901694
[TBL] [Abstract][Full Text] [Related]
9. What human blood-brain barrier models can tell us about BBB function and drug discovery?
Ferreira L
Expert Opin Drug Discov; 2019 Nov; 14(11):1113-1123. PubMed ID: 31385723
[No Abstract] [Full Text] [Related]
10. In vitro modeling of the neurovascular unit: advances in the field.
Bhalerao A; Sivandzade F; Archie SR; Chowdhury EA; Noorani B; Cucullo L
Fluids Barriers CNS; 2020 Mar; 17(1):22. PubMed ID: 32178700
[TBL] [Abstract][Full Text] [Related]
11. BBB-on-a-Chip: Modeling Functional Human Blood-Brain Barrier by Mimicking 3D Brain Angiogenesis Using Microfluidic Chip.
Lee S; Chung M; Jeon NL
Methods Mol Biol; 2022; 2492():251-263. PubMed ID: 35733049
[TBL] [Abstract][Full Text] [Related]
12. Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.
Lin T; Zhao P; Jiang Y; Tang Y; Jin H; Pan Z; He H; Yang VC; Huang Y
ACS Nano; 2016 Nov; 10(11):9999-10012. PubMed ID: 27934069
[TBL] [Abstract][Full Text] [Related]
13. Blood-Vessel-on-a-Chip Platforms for Evaluating Nanoparticle Drug Delivery Systems.
Li Y; Zhu K; Liu X; Zhang YS
Curr Drug Metab; 2018; 19(2):100-109. PubMed ID: 28952434
[TBL] [Abstract][Full Text] [Related]
14. Organ-On-A-Chip Models of the Blood-Brain Barrier: Recent Advances and Future Prospects.
Kawakita S; Mandal K; Mou L; Mecwan MM; Zhu Y; Li S; Sharma S; Hernandez AL; Nguyen HT; Maity S; de Barros NR; Nakayama A; Bandaru P; Ahadian S; Kim HJ; Herculano RD; Holler E; Jucaud V; Dokmeci MR; Khademhosseini A
Small; 2022 Sep; 18(39):e2201401. PubMed ID: 35978444
[TBL] [Abstract][Full Text] [Related]
15. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
[TBL] [Abstract][Full Text] [Related]
16. Advances in Microfluidic Blood-Brain Barrier (BBB) Models.
Oddo A; Peng B; Tong Z; Wei Y; Tong WY; Thissen H; Voelcker NH
Trends Biotechnol; 2019 Dec; 37(12):1295-1314. PubMed ID: 31130308
[TBL] [Abstract][Full Text] [Related]
17. Recent Developments in Microfluidic Technologies for Central Nervous System Targeted Studies.
Teixeira MI; Amaral MH; Costa PC; Lopes CM; Lamprou DA
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32545276
[TBL] [Abstract][Full Text] [Related]
18. From blood to brain: blood cell-based biomimetic drug delivery systems.
Li YJ; Wu JY; Liu J; Qiu X; Xu W; Tang T; Xiang DX
Drug Deliv; 2021 Dec; 28(1):1214-1225. PubMed ID: 34142628
[TBL] [Abstract][Full Text] [Related]
19. Learning from our failures in blood-brain permeability: what can be done for new drug discovery?
Martel S
Expert Opin Drug Discov; 2015 Mar; 10(3):207-11. PubMed ID: 25658294
[TBL] [Abstract][Full Text] [Related]
20. Receptor Targeted Polymeric Nanostructures Capable of Navigating across the Blood-Brain Barrier for Effective Delivery of Neural Therapeutics.
Dube T; Chibh S; Mishra J; Panda JJ
ACS Chem Neurosci; 2017 Oct; 8(10):2105-2117. PubMed ID: 28768412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
